Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia Meca-Lallana

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2020
COVID-19 will change MS care forever - YesVirginia Meca-Lallana
Multiple Sclerosis and Related Disorders|July 30, 2018
Tumefactive multiple sclerosis lesions associated with fingolimod treatment: Report of 5 casesPedro Sánchez, Virginia Meca-Lallana, José Vivancos
Multiple Sclerosis and Related Disorders|August 24, 2019
Cytomegalovirus primary infection in a patient with multiple sclerosis treated with alemtuzumabClara Aguirre, Virginia Meca-Lallana, Pedro Sánchez, et al.
Journal of the Neurological Sciences|October 10, 2017
Tumefactive demyelinating lesions of 15 patients: Clinico-radiological features, management and review of the literaturePedro Sánchez, Virginia Meca-Lallana, Antonio Barbosa, et al.
Multiple Sclerosis and Related Disorders|June 13, 2020
Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?Clara Aguirre, Virginia Meca-Lallana, Ana Barrios-Blandino, et al.
Multiple Sclerosis International|June 27, 2022
Disability and Fatigue in Multiple Sclerosis: Can Rehabilitation Improve Them through a Structured Retraining Program?María José Arriaza, Azanzazu Vazquez, Teresa Hernández, et al.
Multiple Sclerosis and Related Disorders|June 26, 2020
COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapiesVirginia Meca-Lallana, Clara Aguirre, Beatrizdel Río, et al.
Revista De Neurologia|October 2, 2013
[CLIPPERS syndrome with atypical distribution of lesions in magnetic resonance imaging of the brain]Beatrice Canneti, Antonio J Mosqueira, Francisco Gilo, et al.
Neurodegenerative Disease Management|September 8, 2016
A consensus initiative for the assessment of patients newly diagnosed with multiple sclerosis in Spain: the eXamina ProjectVirginia Meca-Lallana, Rafael Arroyo-González, José Meca-Lallana, et al.
Multiple Sclerosis and Related Disorders|November 21, 2024
Observational study of gadolinium-enhancing lesions in MRI in patients with multiple sclerosis from the Spanish Mediterranean coast: Seasonal variability and relationship with climatic factorsCelia Romero Del Rincón, Berta Claramonte-Clausell, Clara Aguirre, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2020
COVID-19 will change MS care forever - YesVirginia Meca-Lallana
Multiple Sclerosis and Related Disorders|July 30, 2018
Tumefactive multiple sclerosis lesions associated with fingolimod treatment: Report of 5 casesPedro Sánchez, Virginia Meca-Lallana, José Vivancos
Multiple Sclerosis and Related Disorders|August 24, 2019
Cytomegalovirus primary infection in a patient with multiple sclerosis treated with alemtuzumabClara Aguirre, Virginia Meca-Lallana, Pedro Sánchez, et al.
Journal of the Neurological Sciences|October 10, 2017
Tumefactive demyelinating lesions of 15 patients: Clinico-radiological features, management and review of the literaturePedro Sánchez, Virginia Meca-Lallana, Antonio Barbosa, et al.
Multiple Sclerosis and Related Disorders|June 13, 2020
Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?Clara Aguirre, Virginia Meca-Lallana, Ana Barrios-Blandino, et al.
Multiple Sclerosis International|June 27, 2022
Disability and Fatigue in Multiple Sclerosis: Can Rehabilitation Improve Them through a Structured Retraining Program?María José Arriaza, Azanzazu Vazquez, Teresa Hernández, et al.
Multiple Sclerosis and Related Disorders|June 26, 2020
COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapiesVirginia Meca-Lallana, Clara Aguirre, Beatrizdel Río, et al.
Revista De Neurologia|October 2, 2013
[CLIPPERS syndrome with atypical distribution of lesions in magnetic resonance imaging of the brain]Beatrice Canneti, Antonio J Mosqueira, Francisco Gilo, et al.
Neurodegenerative Disease Management|September 8, 2016
A consensus initiative for the assessment of patients newly diagnosed with multiple sclerosis in Spain: the eXamina ProjectVirginia Meca-Lallana, Rafael Arroyo-González, José Meca-Lallana, et al.
Multiple Sclerosis and Related Disorders|November 21, 2024
Observational study of gadolinium-enhancing lesions in MRI in patients with multiple sclerosis from the Spanish Mediterranean coast: Seasonal variability and relationship with climatic factorsCelia Romero Del Rincón, Berta Claramonte-Clausell, Clara Aguirre, et al.
Pageof 6